- (1963): “Uncertainty and the welfare economics of medical care,†The American economic review, 53(5), 941–973.
Paper not yet in RePEc: Add citation now
- (1986): “The role of the interaction between the manufacturer and the user in the technological innovation process,†Unpublished Ph. D. dissertation, University of Sussex.
Paper not yet in RePEc: Add citation now
- (1991): “Developing technological innovations within networks,†Entrepreneurship & Regional Development, 3(2), 111–128.
Paper not yet in RePEc: Add citation now
Abadie, A. Diamond, A., and J. Hainmueller (2010): “Synthetic control methods for comparative case studies: Estimating the effect of Californias Tobacco Control Program, †Journal of the American Statistical Association, 105(490), 493–505.
Abadie, A., A. Diamond, and J. Hainmueller (2011): “SYNTH: Stata module to implement Synthetic Control Methods for Comparative Case Studies,†Statistical Software Components.
Abadie, A., and J. Gardeazabal (2003): “The economic costs of conflict: A case study of the Basque Country,†American economic review, pp. 113–132.
Acemoglu, D. (1998): “Why do new technologies complement skills? Directed technical change and wage inequality,†The Quarterly Journal of Economics, 113(4), 1055–1089.
Acemoglu, D., and A. Finkelstein (2008): “Input and Technology Choices in Regulated Industries: Evidence from the Health Care Sector,†Journal of Political Economy, 116(5), 837–880.
Acemoglu, D., and J. Linn (2004): “Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry,†The Quarterly Journal of Economics, 119(3), 1049– 1090.
Aghion, P., A. Dechezleprˆ etre, D. Hemous, R. Martin, and J. Van Reenen (2012): “Carbon taxes, path dependency and directed technical change: evidence from the auto industry,†Discussion paper, National Bureau of Economic Research.
Arrow, K. (1962): “The economic implications of learning by doing,†The review of economic studies, 29(3), 155–173.
- Baicker, K., and A. Chandra (2011): “Aspirin, angioplasty, and proton beam therapy: the economics of smarter health care spending,†in Prepared for Jackson Hole Economic Policy Symposium.
Paper not yet in RePEc: Add citation now
Baicker, K., and D. Goldman (2011): “Patient Cost-Sharing and Health Care Spending Growth,†Journal of Economic Perspectives, 25(2), 47–68.
Berndt, E. R., R. Glennerster, M. R. Kremer, J. Lee, R. Levine, G. Weizs acker, and H. Williams (2007): “Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness,†Health Economics, 16(5), 491–511.
Blume-Kohout, M., and N. Sood (2008): “The Impact of Medicare Part D on Pharmaceutical R&D,†NBER Working Papers 13857, National Bureau of Economic Research, Inc.
Budish, E., B. N. Roin, and H. Williams (2013): “Do fixed patent terms distort innovation ? Evidence from cancer clinical trials,†NBER Working Paper, (w19430).
Chandra, A., and D. O. Staiger (2007): “Productivity Spillovers in Health Care: Evidence from the Treatment of Heart Attacks,†Journal of Political Economy, 115(1), 103– 140.
Chandra, A., and J. Skinner (2012): “Technology Growth and Expenditure Growth in Health Care,†Journal of Economic Literature.
- Chatterji, A., and K. Fabrizio (2011): “How do product users influence corporate invention?,†Organization Science.
Paper not yet in RePEc: Add citation now
- Chatterji, A., K. Fabrizio, W. Mitchell, and K. Schulman (2008): “Physician-industry cooperation in the medical device industry,†Health Affairs, 27(6), 1532–1543.
Paper not yet in RePEc: Add citation now
Clemens, J., and J. Gottlieb (2013): “Bargaining in the Shadow of a Giant: Medicare’s Influence on Private Payment Systems,†NBER Working Papers 19503, National Bureau of Economic Research, Inc. Clemens, J., and J. Gottlieb (Forthcoming): “Do Physicians Financial Incentives Affect Medical Treatment and Patient Health?,†American Economic Review.
- Cutler, D. (2004): Your money or your life: strong medicine for America’s health care system. Oxford University Press, USA.
Paper not yet in RePEc: Add citation now
- Cutler, D. M., and D. P. Ly (2011): “The (Paper) Work of Medicine: Understanding International Medical Costs,†Journal of Economic Perspectives, 25(2), 3–25.
Paper not yet in RePEc: Add citation now
- Cutler, D., A. Rosen, and S. Vijan (2006): “The value of medical spending in the United States, 1960–2000,†New England Journal of Medicine, 355(9), 920–927.
Paper not yet in RePEc: Add citation now
- Cutler, D., and M. McClellan (2001): “Is technological change in medicine worth it?,†Health affairs, 20(5), 11–29.
Paper not yet in RePEc: Add citation now
- Damadian, R. (1974): “Apparatus and Method for Detecting Cancer in Tissue,†US Patent 3,789,832.
Paper not yet in RePEc: Add citation now
De Mouzon, O., P. Dubois, F. Scott Morton, and P. Seabright (2011): “Market Size and Pharmaceutical Innovation,†CEPR Discussion Papers.
Finkelstein, A. (2004): “Static and dynamic effects of health policy: Evidence from the vaccine industry,†The Quarterly Journal of Economics, 119(2), 527–564.
Finkelstein, A. (2007): “The Aggregate Effects of Health Insurance: Evidence from the Introduction of Medicare,†The Quarterly Journal of Economics, 122(1), 1–37.
Finkelstein, A., et al. (2012): “The Oregon Health Insurance Experiment: Evidence from the First Year,†The Quarterly Journal of Economics, 127(3), 1057–1106.
Freedman, S., H. Lin, and K. Simon (2012): “Public Health Insurance Expansions and Hospital Technology Adoption,†Discussion paper.
- Gailey, A., D. Lakdawalla, and N. Sood (2010): “Patents, innovation, and the welfare effects of Medicare Part D,†Advances in Health Economics and Health Services Research, 22, 317–344.
Paper not yet in RePEc: Add citation now
- Glennerster, R., M. Kremer, and H. Williams (2006): “Creating markets for vaccines,†innovations, 1(1), 67–79.
Paper not yet in RePEc: Add citation now
Hall, B., A. Jaffe, and M. Trajtenberg (2001): “The NBER patent citation data file: Lessons, insights and methodological tools,†Discussion paper, National Bureau of Economic Research.
Hall, R. E., and C. . Jones (2007): “The Value of Life and the Rise in Health Spending,†The Quarterly Journal of Economics, 122(1), 39–72.
Jaffe, A., M. Trajtenberg, and P. Romer (2005): Patents, citations, and innovations: A window on the knowledge economy. The MIT Press.
Jones, C. . (2011): “Life and Growth,†NBER Working Papers 17094, National Bureau of Economic Research, Inc.
Kremer, M. (2002): “Pharmaceuticals and the developing world,†The Journal of Economic Perspectives, 16(4), 67–90.
Lakdawalla, D., and N. Sood (2009): “Innovation and the welfare effects of public drug insurance,†Journal of public economics, 93(3), 541–548.
- Ledley, R. (1975): “Diagnostic X-Ray Systems,†US Patent 3,922,552.
Paper not yet in RePEc: Add citation now
- Lettl, C., C. Herstatt, and H. Gemuenden (2006): “Users’ contributions to radical innovation: evidence from four cases in the field of medical equipment technology,†R&D Management, 36(3), 251–272.
Paper not yet in RePEc: Add citation now
Malani, A., and T. Philipson (2011): “Can Medical Progress be Sustained? Implications of the Link Between Development and Output Markets,†Discussion paper, National Bureau of Economic Research.
- Manning, W., et al. (1987): “Health insurance and the demand for medical care: evidence from a randomized experiment,†The American Economic Review, pp. 251–277.
Paper not yet in RePEc: Add citation now
Moser, P. (2011): “Innovation Without Patents-Evidence from the Word Fairs,†Working Paper.
Moser, P., and A. Voena (2012): “Compulsory Licensing: Evidence from the Trading with the Enemy Act,†American Economic Review, 102(1), 396–427.
- Moser, P., K. Bilir, and I. Talis (2011): “Do Treaties Encourage Technology Transfer? Evidence from the Paris Convention,†.
Paper not yet in RePEc: Add citation now
- Murphy, K. M., and R. H. Topel (2003): “The economic value of medical research,†Measuring the gains from medical research: An economic approach, 41.
Paper not yet in RePEc: Add citation now
Newhouse, J. (1992): “Medical care costs: how much welfare loss?,†The Journal of Economic Perspectives, 6(3), 3–21.
- Palmaz, J. (1988): “Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft,†US Patent 4,776,337.
Paper not yet in RePEc: Add citation now
Petersen, M. A. (2009): “Estimating standard errors in finance panel data sets: Comparing approaches,†Review of financial studies, 22(1), 435–480.
Popp, D. (2002): “Induced Innovation and Energy Prices,†American economic review, 92(1), 160–180.
Popp, D., T. Juhl, and D. Johnson (2004): “Time in purgatory: Determinants of the grant lag for US patent applications,†Topics in Economic Analysis and Policy, 4(1), 1–43.
Pozen, A., and D. Cutler (2010): “Medical Spending Differences in the United States and Canada: The Role of Prices, Procedures, and Administrative Expenses,†Inquiry: a journal of medical care organization, provision and financing, 47(2), 124.
- Roberts, E. (1988): “Technological innovation and medical devices,†in New Medical Devices: Invention, Development, and Use, ed. by K. Ekelman, pp. 35–51. National Academy Press, Washington, DC.
Paper not yet in RePEc: Add citation now
- Shaw, B. (1985): “The role of the interaction between the user and the manufacturer in medical equipment innovation,†R&D Management, 15(4), 283–292.
Paper not yet in RePEc: Add citation now
Trajtenberg, M. (1989): “The Welfare Analysis of Product Innovations, with an Application to Computed Tomography Scanners,†Journal of Political Economy, 97(2), pp. 444–479.
Trajtenberg, M. (1990a): “A penny for your quotes: patent citations and the value of innovations,†The Rand Journal of Economics, pp. 172–187.
- Trajtenberg, M. (1990b): “Product innovations, price indices and the (mis) measurement of economic performance,†Discussion paper, National Bureau of Economic Research.
Paper not yet in RePEc: Add citation now
Von Hippel, E. (1976): “The dominant role of users in the scientific instrument innovation process,†Research policy, 5(3), 212–239.
- Wall, W. (1993): “Angioplasty stent,†US Patent 5,192,307.
Paper not yet in RePEc: Add citation now
Weisbrod, B. A. (1991): “The Health Care Quadrilemma: An Essay on Technological Change, Insurance, Quality of Care, and Cost Containment,†Journal of Economic Literature, 29, 523–552.